Cargando…

A case of severe hypothyroidism due to lenalidomide

Lenalidomide, an immunomodulatory drug often used to treat multiple myeloma, can cause hypo‐ or hyperthyroidism. We present a patient being treated with lenalidomide for 2 years who developed severe hypothyroidism that was complicated by rhabdomyolysis and acute kidney injury. Thyroid function tests...

Descripción completa

Detalles Bibliográficos
Autores principales: Blair, Rachel A., Leaf, Rebecca Karp, Leaf, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745361/
https://www.ncbi.nlm.nih.gov/pubmed/31534740
http://dx.doi.org/10.1002/ccr3.2362
_version_ 1783451529660858368
author Blair, Rachel A.
Leaf, Rebecca Karp
Leaf, David E.
author_facet Blair, Rachel A.
Leaf, Rebecca Karp
Leaf, David E.
author_sort Blair, Rachel A.
collection PubMed
description Lenalidomide, an immunomodulatory drug often used to treat multiple myeloma, can cause hypo‐ or hyperthyroidism. We present a patient being treated with lenalidomide for 2 years who developed severe hypothyroidism that was complicated by rhabdomyolysis and acute kidney injury. Thyroid function tests should be serially monitored in patients taking lenalidomide.
format Online
Article
Text
id pubmed-6745361
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67453612019-09-18 A case of severe hypothyroidism due to lenalidomide Blair, Rachel A. Leaf, Rebecca Karp Leaf, David E. Clin Case Rep Case Reports Lenalidomide, an immunomodulatory drug often used to treat multiple myeloma, can cause hypo‐ or hyperthyroidism. We present a patient being treated with lenalidomide for 2 years who developed severe hypothyroidism that was complicated by rhabdomyolysis and acute kidney injury. Thyroid function tests should be serially monitored in patients taking lenalidomide. John Wiley and Sons Inc. 2019-08-08 /pmc/articles/PMC6745361/ /pubmed/31534740 http://dx.doi.org/10.1002/ccr3.2362 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Blair, Rachel A.
Leaf, Rebecca Karp
Leaf, David E.
A case of severe hypothyroidism due to lenalidomide
title A case of severe hypothyroidism due to lenalidomide
title_full A case of severe hypothyroidism due to lenalidomide
title_fullStr A case of severe hypothyroidism due to lenalidomide
title_full_unstemmed A case of severe hypothyroidism due to lenalidomide
title_short A case of severe hypothyroidism due to lenalidomide
title_sort case of severe hypothyroidism due to lenalidomide
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745361/
https://www.ncbi.nlm.nih.gov/pubmed/31534740
http://dx.doi.org/10.1002/ccr3.2362
work_keys_str_mv AT blairrachela acaseofseverehypothyroidismduetolenalidomide
AT leafrebeccakarp acaseofseverehypothyroidismduetolenalidomide
AT leafdavide acaseofseverehypothyroidismduetolenalidomide
AT blairrachela caseofseverehypothyroidismduetolenalidomide
AT leafrebeccakarp caseofseverehypothyroidismduetolenalidomide
AT leafdavide caseofseverehypothyroidismduetolenalidomide